Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Sell
23
EVAX Quote, Financials, Valuation and Earnings
Last price:
$1.38
Seasonality move
:
-7.61%
Day range:
$1.32 - $1.38
52-week range:
$1.20 - $22.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.43x
P/B ratio:
127.87x
Volume:
59.2K
Avg. volume:
78.2K
1-year change:
-93.06%
Market cap:
$8.5M
Revenue:
$3.3M
EPS (TTM):
-$2.80
Earnings Data
Next earnings date for EVAX
May 28
2025
Most recent earnings per share
-$3.50
Missed by $3.35
(Mar 27/2025)
Consensus Estimate
-$0.15
(Mar 27/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
EVAX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $62.5K | -- | -- | -$0.52 | -- |
| 04/01/2025 | Q1 | $60K | -- | -- | -$0.71 | -- |
| 03/27/2025 | Q4 | $1.7M | $122K | -$3.50 | -$0.15 | -$3.35 |
| 10/31/2024 | Q3 | -- | $3M | -$2.00 | -$0.12 | -$1.88 |
| 08/14/2024 | Q2 | $52K | $154K | -$6.00 | -$3.50 | -$2.50 |
| 05/28/2024 | Q1 | -- | $51K | $1.50 | -$4.95 | $6.45 |
| 03/27/2024 | Q4 | -- | $73K | -$7.50 | -$8.00 | $0.50 |
| 12/19/2023 | Q3 | -- | -- | -$10.50 | -$9.75 | -$0.75 |
| 08/18/2023 | Q2 | -- | -- | -$10.50 | -$10.75 | $0.25 |
| 05/31/2023 | Q1 | -- | -- | -$12.00 | -$12.00 | -- |
| 03/22/2023 | Q4 | -- | -- | -$14.50 | -$13.17 | -$1.33 |
| 11/14/2022 | Q3 | -- | -- | -$12.00 | -$13.33 | $1.33 |
| 08/10/2022 | Q2 | -- | -- | -$10.00 | -- | -- |
| 05/11/2022 | Q1 | -- | -- | -$12.50 | -- | -- |
| 03/22/2022 | Q4 | -- | -- | -$19.50 | -- | -- |
| 11/09/2021 | Q3 | -- | -- | -$13.50 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$18.00 | -- | -- |
| 05/13/2021 | Q1 | -- | -- | -$11.50 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$13.18 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$12.38 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$9.48 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$8.07 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$9.16 | -- | -- |
Evaxion Biotech AS Earnings Questions
-
How Much did Evaxion Biotech AS Generate in Revenue Last Quarter?
Evaxion Biotech AS reported $122K worth of top line sales in its most recent quarter.
-
Did Evaxion Biotech AS Beat Earnings Last Quarter?
Evaxion Biotech AS announced earnings per share of -$3.50 which represents a miss of analyst forecast a -$0.15 per share.
-
Is Evaxion Biotech AS Profitable?
Evaxion Biotech AS reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Evaxion Biotech AS EPS Next Year?
Evaxion Biotech AS's earnings are forecast to decrease from -$10.00 per share to -$1.79 per share next year representing a decrease of -82.13%.
-
When is Evaxion Biotech AS's Earnings Date?
Evaxion Biotech AS's next earnings date is May 28, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Is Bloom Energy Stock a Buy, Sell or Hold?
While already interesting as the world moves toward greener energy…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
